Oncology is one island where biotech investment continues in the sea of shrinking biopharma. As expected, the current environment is also conducive to oncology biotech companies being lost to mergers and acquisitions. Sadly, these carefully crafted and nurtured brands will be lost for ever!
Oncology targets, strategies, cancer drug development and personalized medicine
Showing posts with label biotech biz. Show all posts
Showing posts with label biotech biz. Show all posts
Saturday, December 31, 2011
Subscribe to:
Posts (Atom)